204 related articles for article (PubMed ID: 31494100)
1. Use of tumour necrosis factor-α inhibitors and the risk of serious infection in paediatric inflammatory bowel disease in Denmark: a nationwide cohort study.
Wintzell V; Svanström H; Melbye M; Jess T; Olén O; Ludvigsson JF; Pasternak B
Lancet Gastroenterol Hepatol; 2019 Nov; 4(11):845-853. PubMed ID: 31494100
[TBL] [Abstract][Full Text] [Related]
2. Association between use of azathioprine and risk of acute pancreatitis in children with inflammatory bowel disease: a Swedish-Danish nationwide cohort study.
Wintzell V; Svanström H; Olén O; Melbye M; Ludvigsson JF; Pasternak B
Lancet Child Adolesc Health; 2019 Mar; 3(3):158-165. PubMed ID: 30685366
[TBL] [Abstract][Full Text] [Related]
3. Anti-tumour necrosis factor-α therapy and recurrent or new primary cancers in patients with inflammatory bowel disease, rheumatoid arthritis, or psoriasis and previous cancer in Denmark: a nationwide, population-based cohort study.
Waljee AK; Higgins PDR; Jensen CB; Villumsen M; Cohen-Mekelburg SA; Wallace BI; Berinstein JA; Allin KH; Jess T
Lancet Gastroenterol Hepatol; 2020 Mar; 5(3):276-284. PubMed ID: 31836320
[TBL] [Abstract][Full Text] [Related]
4. Association between tumour necrosis factor-α inhibitors and risk of serious infections in people with inflammatory bowel disease: nationwide Danish cohort study.
Nyboe Andersen N; Pasternak B; Friis-Møller N; Andersson M; Jess T
BMJ; 2015 Jun; 350():h2809. PubMed ID: 26048617
[TBL] [Abstract][Full Text] [Related]
5. Risk of Serious Bacterial Infection Associated With Tumor Necrosis Factor-Alpha Inhibitors in Children and Young Adults With Inflammatory Bowel Disease.
Lee WJ; Lee TA; Calip GS; Suda KJ; Briars L; Schumock GT
Inflamm Bowel Dis; 2018 Mar; 24(4):883-891. PubMed ID: 29562275
[TBL] [Abstract][Full Text] [Related]
6. Increased risk of developing Crohn's disease or ulcerative colitis in 17 018 patients while under treatment with anti-TNFα agents, particularly etanercept, for autoimmune diseases other than inflammatory bowel disease.
Korzenik J; Larsen MD; Nielsen J; Kjeldsen J; Nørgård BM
Aliment Pharmacol Ther; 2019 Aug; 50(3):289-294. PubMed ID: 31267570
[TBL] [Abstract][Full Text] [Related]
7. Colorectal cancer in Crohn's disease: a Scandinavian population-based cohort study.
Olén O; Erichsen R; Sachs MC; Pedersen L; Halfvarson J; Askling J; Ekbom A; Sørensen HT; Ludvigsson JF
Lancet Gastroenterol Hepatol; 2020 May; 5(5):475-484. PubMed ID: 32066530
[TBL] [Abstract][Full Text] [Related]
8. Long-Term Safety of In Utero Exposure to Anti-TNFα Drugs for the Treatment of Inflammatory Bowel Disease: Results from the Multicenter European TEDDY Study.
Chaparro M; Verreth A; Lobaton T; Gravito-Soares E; Julsgaard M; Savarino E; Magro F; Biron AI; Lopez-Serrano P; Casanova MJ; Gompertz M; Vitor S; Arroyo M; Pugliese D; Zabana Y; Vicente R; Aguas M; Shitrit BA; Gutierrez A; Doherty GA; Fernandez-Salazar L; Cadilla MJ; Huguet JM; OʼToole A; Stasi E; Marcos MN; Villoria A; Karmiris K; Rahier JF; Rodriguez C; Palomares DM; Fiorino G; Benitez JM; Principi M; Naftali T; Taxonera C; Mantzaris G; Sebkova L; Iade B; Lissner D; Bradley FI; Roman LA; Marin-Jimenez I; Merino O; Sierra M; Van Domselaar M; Caprioli F; Guerra I; Peixe P; Piqueras M; Rodriguez-Lago I; Ber Y; van Hoeve K; Torres P; Gravito-Soares M; Rudbeck-Resdal D; Bartolo O; Peixoto A; Martin G; Armuzzi A; Garre A; Donday MG; de Carpi MFJ; Gisbert JP
Am J Gastroenterol; 2018 Mar; 113(3):396-403. PubMed ID: 29460920
[TBL] [Abstract][Full Text] [Related]
9. Management of inflammatory bowel disease with infliximab and other anti-tumor necrosis factor alpha therapies.
Magro F; Portela F
BioDrugs; 2010 Dec; 24 Suppl 1():3-14. PubMed ID: 21175228
[TBL] [Abstract][Full Text] [Related]
10. Comparative risk of incident venous thromboembolism in patients with inflammatory bowel disease initiating tumour necrosis factor-α inhibitors or nonbiologic agents: a cohort study.
Desai RJ; Gagne JJ; Lii J; Liu J; Friedman S; Kim SC
CMAJ; 2017 Nov; 189(47):E1438-E1447. PubMed ID: 29180383
[TBL] [Abstract][Full Text] [Related]
11. Continuous Anti-TNFα Use Throughout Pregnancy: Possible Complications For the Mother But Not for the Fetus. A Retrospective Cohort on the French National Health Insurance Database (EVASION).
Luu M; Benzenine E; Doret M; Michiels C; Barkun A; Degand T; Quantin C; Bardou M
Am J Gastroenterol; 2018 Nov; 113(11):1669-1677. PubMed ID: 29961771
[TBL] [Abstract][Full Text] [Related]
12. Inflammatory Bowel Disease Patients Are at Increased Risk of Invasive Pneumococcal Disease: A Nationwide Danish Cohort Study 1977-2013.
Kantsø B; Simonsen J; Hoffmann S; Valentiner-Branth P; Petersen AM; Jess T
Am J Gastroenterol; 2015 Nov; 110(11):1582-7. PubMed ID: 26346865
[TBL] [Abstract][Full Text] [Related]
13. Colorectal cancer in ulcerative colitis: a Scandinavian population-based cohort study.
Olén O; Erichsen R; Sachs MC; Pedersen L; Halfvarson J; Askling J; Ekbom A; Sørensen HT; Ludvigsson JF
Lancet; 2020 Jan; 395(10218):123-131. PubMed ID: 31929014
[TBL] [Abstract][Full Text] [Related]
14. Psychological stress and inflammatory bowel disease: a follow-up study in parents who lost a child in Denmark.
Li J; Nørgard B; Precht DH; Olsen J
Am J Gastroenterol; 2004 Jun; 99(6):1129-33. PubMed ID: 15180736
[TBL] [Abstract][Full Text] [Related]
15. The impact of anti-TNFα therapy on colectomy rates and corticosteroid treatment among 3001 paediatric and adolescent patients with ulcerative colitis-a nationwide study from 1995 to 2015.
Lund K; Larsen MD; Knudsen T; Kjeldsen J; Nielsen RG; Nørgård BM
Aliment Pharmacol Ther; 2019 Nov; 50(10):1077-1085. PubMed ID: 31579961
[TBL] [Abstract][Full Text] [Related]
16. Serious Infections in Pediatric Inflammatory Bowel Disease 2002-2017-A Nationwide Cohort Study.
Ludvigsson JF; Sachs MC; Järås J; Malmborg P; Olén O
J Pediatr; 2021 Nov; 238():66-73.e1. PubMed ID: 34216628
[TBL] [Abstract][Full Text] [Related]
17. Use of Anti-TNFα Agents and Time to First-time Surgery in Paediatric Patients with Ulcerative Colitis and Crohn's Disease.
Larsen MD; Qvist N; Nielsen J; Kjeldsen J; Nielsen RG; Nørgård BM
J Crohns Colitis; 2016 Jun; 10(6):650-6. PubMed ID: 26802081
[TBL] [Abstract][Full Text] [Related]
18. Increased Mortality of Patients With Childhood-Onset Inflammatory Bowel Diseases, Compared With the General Population.
Olén O; Askling J; Sachs MC; Frumento P; Neovius M; Smedby KE; Ekbom A; Malmborg P; Ludvigsson JF
Gastroenterology; 2019 Feb; 156(3):614-622. PubMed ID: 30342031
[TBL] [Abstract][Full Text] [Related]
19. Maternal Inflammatory Bowel Disease During Pregnancy and Infectious Disease in Offspring Younger Than 5 Years: A Population-Based Cohort Study.
Ren T; Yu Y; Wang H; Li F; Zhang J; Li J
Am J Gastroenterol; 2023 Mar; 118(3):491-500. PubMed ID: 36695745
[TBL] [Abstract][Full Text] [Related]
20. Long-term outcome of inflammatory bowel disease patients with deep remission after discontinuation of TNFα-blocking agents.
Molander P; Färkkilä M; Kemppainen H; Blomster T; Jussila A; Mustonen H; Sipponen T
Scand J Gastroenterol; 2017 Mar; 52(3):284-290. PubMed ID: 27806638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
